CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 96 filers reported holding CARDIFF ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,990 | -77.6% | 41,000 | -76.3% | 0.00% | -100.0% |
| Q2 2023 | $254,016 | +7.3% | 172,800 | +20.4% | 0.00% | 0.0% |
| Q1 2023 | $236,775 | -9.5% | 143,500 | -23.2% | 0.00% | 0.0% |
| Q4 2022 | $261,660 | -13.6% | 186,900 | -4.9% | 0.00% | 0.0% |
| Q3 2022 | $303,000 | -58.9% | 196,500 | -41.3% | 0.00% | -50.0% |
| Q2 2022 | $737,000 | -42.2% | 334,800 | -34.9% | 0.00% | -33.3% |
| Q1 2022 | $1,275,000 | -68.1% | 514,100 | -22.7% | 0.00% | -70.0% |
| Q4 2021 | $3,997,000 | -14.4% | 665,000 | -5.1% | 0.01% | -16.7% |
| Q3 2021 | $4,667,000 | +5.5% | 700,800 | +5.4% | 0.01% | 0.0% |
| Q2 2021 | $4,424,000 | -18.5% | 665,200 | +13.5% | 0.01% | -20.0% |
| Q1 2021 | $5,425,000 | +154.9% | 585,900 | +395.3% | 0.02% | +150.0% |
| Q4 2020 | $2,128,000 | – | 118,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
| Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
| Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
| Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
| Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
| Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
| Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |